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Introduction: Low plasma selenium concentrations are frequent in critically ill patients. However, whether this is
due to systemic inflammation, a deficient nutritional state or both is still not clear. We aimed to determine the
factors associated with low plasma selenium in critically ill children while considering the inflammatory response
and nutritional status.
Method: A prospective study was conducted in 173 children (median age 34 months) with systemic inflammatory
response who had plasma selenium concentrations assessed 48 hours after admission and on the 5th day of ICU
stay. The normal reference range was 0.58 μmol/L to 1.6 μmol/L. The outcome variable was ‘low plasma selenium’,
which was defined as plasma selenium values below the distribution median during this period. The main explanatory
variables were age, malnutrition, sepsis, C-reactive protein (CRP), and clinical severity scores. The data were analyzed
using a Binomial Generalized Estimating Equations model, which includes the correlation between admission and 5th
day responses.
Results: Malnutrition and CRP were associated with low plasma selenium. The interaction effect between these two
variables was significant. When CRP values were less than or equal to 40 mg/L, malnutrition was associated with low
plasma selenium levels (odds ratio (OR) = 3.25, 95% confidence interval (CI) 1.39 to 7.63, P = 0.007; OR = 2.98, 95% CI
1.26 to 7.06, P = 0.013; OR = 2.49, 95% CI 1.01 to 6.17, P = 0.049, for CRP = 10, 20 and 40 mg/L, respectively). This effect
decreased as CRP concentrations increased and there was loose significance when CRP values were >40 mg/L. Similarly,
the effect of CRP on low plasma selenium was significant for well-nourished patients (OR = 1.13; 95% CI 1.06 to 1.22,
P <0.001) but not for the malnourished (OR = 1.03; 95% CI 0.99 to 1.08, P = 0.16).
Conclusions: There is a significant interaction between the magnitude of the inflammatory response and malnutrition
on low plasma selenium. This interaction should be considered when interpreting plasma concentrations as an index of
selenium status in patients with systemic inflammation as well as in the decision on selenium supplementation.Introduction
Selenium plays an essential role in the protection against
lipid peroxidation, in regulating T cell activity, mediating
the inflammatory response and aiding thyroid hormone
metabolism. The biological effects of selenium are achieved
by 25 selenoproteins, among which the most known are
selenoprotein P, the glutathione peroxidases, thioredoxin
reductases and iodothyronine deiodinases [1]. Plasma* Correspondence: heitorpons@gmail.com
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otherwise stated.selenium is predominantly associated with three proteins:
selenoprotein P, which comprises over 50% of plasma
selenium, glutathione peroxidase and albumin, which
accounts for 20 to 40% and 9% of plasma selenium, respect-
ively [2]. Plasma concentration reflects a very low part of
body selenium as there is only 0.2 mg selenium in plasma
for 20 to 40 mg in the whole body [3].
Decreased plasma concentrations during the acute phase
response have been described in animal and clinical studies
[4,5]. Plasma selenium is reportedly significantly lower in
critically ill adult patients compared with healthy subjects
[6-10] and is associated with oxidative stress, infectioused Central Ltd. This is an Open Access article distributed under the terms of the
reativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution,
original work is properly credited. The Creative Commons Public Domain
/publicdomain/zero/1.0/) applies to the data made available in this article, unless
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[8,9,11,12]. However, in an international, randomized,
blind trial conducted in patients with multiorgan failure,
the North American patients did not show the low
plasma selenium concentrations consistently observed
in European and South American trials of selenium status
in critically ill and healthy people. These differences were
attributed to the depletion of selenium in soil observed in
parts of Europe but not in North America [13]. There are
few data about the natural abundance of selenium in
Brazilian soils, as well as on the intake of selenium by
the population. Evidence of low intake of selenium is
reported in São Paulo, an area considered to have a
selenium-deficient soil [14,15].
Low plasma selenium concentrations have also been
reported in critically ill children [16-18]. However, the
extent to which low plasma selenium concentrations
reflect systemic inflammation, a selenium-deficient nutri-
tional status or both is still not clear. The assessment of
selenium nutritional status by biomarkers should ideally
consider the high prevalence of malnutrition in ICUs
[19,20] as well as a previous selenium deficiency. Correct
analyses of these data are important for nutritional man-
agement of the critically ill patient. To date, there are
no studies assessing the influence of malnutrition on
selenium plasma concentrations in patients with systemic
inflammation.
Based on the hypothesis that selenium plasma concen-
trations in children that are admitted to the ICU are
reduced compared with normal standards, especially in
malnourished patients, we sought to understand the risk
factors that are associated with low plasma selenium
concentrations in critically ill children while taking
patient nutritional status and the magnitude of the
systemic inflammatory response into account.
Methods
This prospective observational study was conducted in a
teaching hospital ICU with level I accreditation [21].
One hundred and seventy-three children who were
admitted between July 2009 and May 2011 with systemic
inflammatory responses were eligible for inclusion in the
study. Neonates were excluded, as well as children with
liver or kidney diseases; patients who were expected to be
admitted for less than 24 hours, those with encephalic
death, and readmissions were also excluded. The study
was approved by the Research Ethics Committee of
Federal University of São Paulo and written informed
consent was obtained from the parents of each patient.
Nutritional therapy was performed according to the
ICU protocol and was initiated after nutritional status
assessment in the setting of hemodynamic stability.
Patients were considered as hemodynamically stable if
they were not hypotensive and did not require significanthemodynamic support including high-dose catecholamine
agents, alone or in combination with large-volume
fluid or blood product resuscitation to maintain cellu-
lar perfusion [22]. Feeding was preferably delivered by
the enteral route. Energy requirements for the systemic
inflammatory response acute phase were calculated
according to the predicted basal metabolic rate, initially
50% of the total volume. The infusion rate increased every
12 to 24 hours, if tolerated, to reach 100% of total esti-
mated volume by day two [23].Variables
The outcome variable was ‘low plasma selenium’, which
was defined as plasma selenium value below the distri-
bution median. The following factors were considered to
be exposure variables that could potentially affect the
outcome: age, gender, nutritional status upon admission,
diagnosis of severe sepsis/septic shock on admission,
magnitude of the inflammatory response as measured by
serum C-reactive protein (CRP) concentrations, albumin
and lactate serum concentrations, clinical severity upon
admission and organ dysfunction scores.Laboratory analyses
Blood samples for plasma selenium, CRP, serum albumin,
and lactate concentration analysis were obtained at an
average time of 48 hours after admission and on the
5th day of ICU stay. Plasma selenium concentration
was determined using graphite furnace atomic absorption
spectrophotometry with Zeeman background correction.
The normal reference range was 0.58 μmol/L to 1.6 μmol/
L, which corresponded to the mean values proposed for
the healthy pediatric population [24].
Serum CRP concentrations were assessed by turbidim-
etry [25] on the basis of a reference normality value ≤10
mg/L for acute-phase inflammatory responses. Serum
albumin and lactate analyses were performed using the
colorimetric method, with normal lactate concentrations
defined as ≤2 mMol/L.Nutritional status assessment
For nutritional status classification, the anthropometric
indicators weight for age (W/A), height for age (H/A)
and body mass index (BMI) were compared against the
World Health Organization 2006 growth standards [26].
For children younger than 2 years, we used the W/A or
H/A whereas the BMI was used for children older than
2 years of age. Patients with an anthropometric index z
score below –2 were considered malnourished. Calculations
were performed using the World Health Organization
Anthroplus software (version 1.0.2; World Health Organ-
ization, Geneva, Switzerland).
Table 1 Main clinic and demographic characteristics of
the patients at admission (n = 173)
Variable Values
Age* (months) 34 (9-90)
Male gender - n (%) 106 (61)
Nutritional status - n (%)
Well nourished 90 (52.0)
Malnourished 80 (46.3)
Obese/overweight 3 (1.7)
Mortality n (%) 11 (6.3)
PIM 2* 3.68 (1.32 – 8.78)
PELOD (on admission)* 11 (2-12)
ICU-free days (days)* 21 (15-24)
Length of hospital stay (days)* 15 (10-27)
Ventilator-free days (days)* 24 (20-27)
Diagnostic groups - n (%)
Surgical 77 (44.5)
Cardiovascular 36 (46.7)
Gastrointestinal 13 (17)
Neurological 11 (14.2)
Miscellaneous 17 (22.1)
Medical 96 (55.5)
Respiratory 70 (73)
Cardiovascular 7 (7.2)
Gastrointestinal 7 (7.2)
Neurological 8 (8.4)
Endocrine/Metabolic 4 (4.2)
*Data expressed as median and interquartile range. PIM 2, revised Pediatric
Index of Mortality; PELOD, Pediatric Logistic Organ Dysfunction score.
Table 2 Comparative analysis between laboratory
parameters on admission and on the 5th day of ICU stay -
patients with at least 5 days of ICU stay (n = 99)
Day of assessment
Variables Admission 5th day P value
Selenium* (μmol/L) 0.30 (0.15-0.39) 0.32 (0.20-0.49) <0.001w
CRP* (mg/L) 49.3 (18.8-112.9) 29.4 (7.0-73.5) <0.001w
Lactate* (mMol/L) 1.0 (0.8-1.5) 1.0 (0.7-1.4) 0.21w
Albumin** (g/dL) 3.0 ± 0.61 3.29 ± 0.53 <0.001t
*Data expressed as median and interquartile range; **data expressed as the mean
and standard deviation; WWilcoxon test; tpaired t test. CRP, C-reactive protein.
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Clinical severity scores on admission were assessed ac-
cording to the Revised Pediatric Index of Mortality (PIM
2) [27]. The Pediatric Logistic Organ Dysfunction score
(PELOD) [28] score was used to assess multiple organ
dysfunction severity on the day of admission. Systemic
inflammatory response syndrome, severe sepsis, and sep-
tic shock were defined according to pediatric consensus
terminology [29]. ICU-free days were defined as days
not needing ICU care in the first 28 days after admission.
Subjects who did not survive to day 28 or who stayed in
the ICU for 28 days or more were assigned zero ICU-
free days. Ventilator-free days were defined as the num-
ber of days alive and breathing without assistance from
admission to day 28. Subjects who did not survive to
day 28 were assigned zero ventilator-free days [30].
Statistical analysis
Categorical data were summarized using frequencies and
percentages, and normally distributed or non-normal
quantitative data were summarized using means and
standard deviations or median and interquartile range.
Laboratory parameters observed on admission and on
the 5th day of ICU stay were compared using a paired t
test and the Wilcoxon test.
Two approaches were used to evaluate the effect of
explanatory variables on the outcome: first, using only
admission values and second, with the two measurements
(admission and 5th day). In the first approach, logistic
regression models were fitted. Generalized estimating
equation (GEE) models with binomial distribution were
used in the second approach, because they take the
dependence observed between two values within a patient
into account. Univariate and multivariate analyses were
performed in both approaches. Variables with a P <0.10 in
the univariate models were selected for the multivariate
model. The interaction terms among variables, which
remained in the final models, were investigated. The
significance level was set to 0.05. Intercooled Stata 10.0
(StataCorp LP, College Station, TX, USA) software was
used to perform the analysis.
Results
The main patient characteristics are summarized in
Table 1. Blood samples were collected from all patients on
admission and from 99 of these patients who remained in
the ICU until day 5. Median plasma selenium concentra-
tion at admission was 0.29 μmol/L (interquartile range
0.18 to 0.38 μmol/L); values below the lower limit of
normal (0.58 μmol/L) were observed in 90.7% (157/173)
of patients. Other laboratory values at admission were
as follows: the median CRP concentration was 45.1 mg/L
(interquartile range 12.5 to 111.9 mg/L), albumin (mean ±
SD) was 3.12 ± 0.67 g/dL and median lactate was 1.0mMol/L (interquartile range 0.8 to 1.6 mMol/L). CRP
concentrations decreased from admission to 5th day while
the other variables remained relatively constant (Table 2).
Selenium concentrations persisted below normal levels in
82 of the 99 patients who remained in the ICU until day 5.
The mean daily intake of selenium was 6.8 μg (range 0 to
48.7 μg) and only six patients achieved the Estimated
Average Requirement or Adequate Intake for selenium
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for age and CRP, selenium intake was not related to a
decreased risk of low plasma selenium on day 5
The outcome ‘low plasma selenium’, defined by plasma
selenium concentration below the distribution median
(≤0.29 μmol/L on admission and ≤0.32 μmol/L on the
5th day of ICU stay, respectively) was analyzed at the
two time points (admission and hospitalization day 5).
Low plasma selenium on admission
Univariate and multivariate analyses of exposure variables
for low plasma selenium at admission are demonstrated
in Table 3. Malnutrition and CRP concentrations on
admission were statistically associated with the final
model outcome.
To better understand the interference of malnutrition
and CRP on low plasma selenium, the interaction between
these variables was studied and demonstrated to be statis-
tically significant (P = 0.035). Interaction between variables
is present when the effect of one predictor variable on
the outcome varies according to the other independent
variable. In our study, the significant interaction suggests
that the effect of malnutrition on the outcome (low
plasma selenium) depends on CRP concentration and the
effect of CRP on the outcome depends on whether the
child is malnourished or not. This result will be described
in detail in the analysis of the two time points (admission
and on day 5).
Low plasma selenium at the two time points (admission
and hospitalization day 5)
Univariate and multivariate analyses of exposure variables
for low plasma selenium on admission and day 5 are
demonstrated in Table 4. The results are very close to
those that were found in the low plasma selenium onTable 3 Effect of exposure variables on low plasma
selenium on admission
Univariate analysis Multivariate analysis
Variables OR (95% CI) P value OR (95% CI) P value
Male gender 0.70 (0.38-1.29) 0.25 - -
Age (months) 0.99 (0.99-1.00) 0.50 - -
PELOD 1.02 (0.98-1.07) 0.25 - -
PIM 2 1.01 (0.99-1.04) 0.24 - -
Surgical 1.07 (0.59-1.05) 0.82 -
Sepsis/septic shock 2.48 (0.62-9.93) 0.199 - -
Malnutrition 2.39 (1.30-4.41) 0.005 2.05 (1.07-3.90) 0.03
CRP (x 10 mg/dL) 1.08 (1.03-1.12) 0.001 1.06 (1.01-1.11) 0.025
Albumin (g/dL) 0.63 (0.39-0.99) 0.048 0.88 (0.55-1.49) 0.65
Lactate (mMol/L) 1.00 (0.98-1.03) 0.73 - -
Univariate and multivariate logistic regression analyses (n = 173). OR, odds
ratio; CI, confidence interval; PELOD, Pediatric Logistic Organ Dysfunction
score; PIM 2, revised Pediatric Index of Mortality; CRP, C-reactive protein.admission analysis (Table 3). CRP values on admission
and malnutrition were significantly associated with low
plasma selenium for both evaluation time points.
Such as for the analysis of the outcome on admission,
there was a significant interaction between CRP concen-
trations and malnutrition (P = 0.03). To better evaluate
this result, estimates of the effects of these two variables
on patient outcome are presented in Table 5. The effect
of CRP concentrations on low plasma selenium was
significant in well-nourished (P <0.001) but not in mal-
nourished patients (P = 0.16). The effect of malnutrition
on low plasma selenium also decreased according to the
CRP concentration increase and was no longer significant
from values >40 mg/L (Figure 1). This cutoff value for
CRP derived from the statistical interaction between CRP
values and malnutrition.
Discussion
Plasma selenium concentrations were below the normal
range in most patients during the study period. Because
infants have a high metabolic rate and faster growth,
they are expected to represent a high-risk age group for
deficiency. Since there are no reference values for
plasma selenium in normal Brazilian children, the refer-
ence recommended by the laboratory were adopted in
our study. The reference values for plasma selenium
concentrations must be adjusted for age because serum
selenium concentrations in childhood show a significant
age dependency [24]. We found three studies in the
literature that evaluated plasma selenium levels during
the systemic inflammatory response in children that
had been admitted to the ICU [16-18]. Plasma selenium
concentrations were below the reference values in up
to 82% of patients, but no studies considered patient
nutritional status and the magnitude of the inflammatory
response.
We did not find correlation between plasma selenium
and severity of illness indices. In another pediatric study,
weak correlations were found between these variables,
suggesting that other factors may affect plasma selenium
and severity of illness [18].
Plasma concentration analysis is the most commonly
used method for selenium determination [31]. However,
plasma concentrations of some micronutrients may be
affected by systemic inflammation, which may confound
the low plasma concentrations, which indicate deficiency
[32,33]. The main factor responsible for reduced plasma
concentrations during the systemic inflammatory response
is, hypothetically, selenium redistribution from the circula-
tion to tissues that are involved in immune function.
Endothelial injury results in increased vascular permeabil-
ity favoring transcapillary escape of selenium transporter
proteins [34]. In addition to ischemia-induced local acid-
osis which causes selenoprotein P binding to the activated
Table 4 Effect of exposure variables on low plasma selenium (admission and day 5)
Univariate analysis Multivariate analysis
Variables OR (CI 95%) P value OR (CI 95%) P value
Male gender 0.69 (0.39-1.21) 0.19 - -
Age (months) 1.00 (0.99-1.00) 0.11 - -
PELOD 1.03 (0.99-1.07) 0.16 - -
PIM 2 1.17 (0.67-2.04) 0.58 - -
Surgical 1.07 (0.61-1.86) 0.82 -
Sepsis/septic shock 1.44 (0.43-4.89) 0.55 - -
Malnutrition 2.04 (1.15-3.62) 0.005 1.88 (1.05-3.39) 0.035
CRP on admission (x 10 mg/L) 1.08 (1.04-1.13) <0.001 1.06 (1.02-1.11) 0.007
Albumin (g/dL) 0.59 (0.38-0.92) 0.018 0.88 (0.53-1.43) 0.58
Lactate (mMol/L) 1.00 (0.98-1.02) 0.89 - -
Results of the generalized estimating equations models (GEE). OR, odds ratio; CI, confidence interval; PELOD, Pediatric Logistic Organ Dysfunction score; PIM 2,
revised Pediatric Index of Mortality; CRP, C-reactive protein.
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dialysis, and low intake contribute to low plasma selenium
concentrations in critically ill patients [11]. The molecular
mechanisms that lead to reduced serum selenium during
the acute phase response have been studied in animal
models. In a study in mice, the authors demonstrated that
genes essential for selenium metabolism are downregu-
lated as part of the acute-phase response and impair
regular selenoprotein P biosynthesis by hepatocytes [37].
Experimental data also indicate that kinetics of plasma
selenium during the early stages of systemic inflamma-
tion are quite similar in mammals [4,5,37,38]. Very early
decreases in plasma selenium concentrations have been
reported after an endotoxemia-induced acute response in
rats [5] and in an ovine model of septic shock [38]. In a
study to evaluate the time-dependent changes in plasma
trace elements in rats following burn injury, plasma selen-
ium decreased six hours post injury with no detectable
changes in tissue selenoenzymes activity [4], suggestingTable 5 Effects of CRP concentrations and malnutrition
on low plasma selenium
Effects OR 95% CI P
Effect of CRP (x 10 mg/L)
Well-nourished patients 1.13 1.06-1.22 <0.001
Malnourished patients 1.03 0.99-1.08 0.16
Effect of malnutrition*
Patients with 10 mg/L CRP 3.25 1.39-7.63 0.007
Patients with 20 mg/L CRP 2.97 1.255-7.06 0.013
Patients with 40 mg/L CRP 2.49 1.01-6.17 0.049
Patients with 60 mg/L CRP 2.09 0.79-5.53 0.14
Patients with 80 mg/L CRP 1.74 0.60-5.07 0.31
*Comparison between malnourished and well-nourished patients regarding the
chance of low plasma selenium concentrations; OR, odds ratio; CI, confidence
interval; CPR, C-reactive protein.evidence in favor of a conserved tissue selenoenzymes
activity during acute inflammation.
Apart from the systemic inflammatory response, selen-
ium deficiency should be understood as a true low selen-
ium status with decreased tissue selenoenzyme activity [39]
and that this deficiency leads to low plasma selenium con-
centration, as well as low selenoprotein P or glutathione
peroxidase [40,41]. In addition, considering that selenium
content in plasma is a very small part of body selenium
content (0.5 to 1%) one cannot deduce from a low plasma
selenium concentration a low tissue selenoenzyme activity
and thus a true selenium deficiency [3].
Serial serum CRP concentration monitoring may be
useful to provide a more accurate interpretation of plasma
selenium concentration as a nutritional deficiency indica-
tor. In a recent cross-sectional study on a large blood
sample from adult patients with various types of medical
conditions, selenium and other micronutrient plasma
concentrations decreased with inflammatory response
intensity as assessed by CRP. The authors suggested
plasma micronutrient concentrations can only be clinically
interpreted with knowledge of the degree of inflammatory
response. According to their results, plasma selenium
concentration assessment would be feasible if CRP
values were lower than 10 mg/L [42]. Given that these
were the results of routine micronutrient screens that
were extracted from the laboratory database, patient
clinical and nutritional status was not considered. The
studies in which nutritional status was considered a risk
factor for low plasma selenium concentrations were all
performed in kwashiorkor [43], HIV [44,45] and tubercu-
losis [46] patients, which is different from the children
that were admitted to the ICU.
We evaluated plasma selenium concentrations in crit-
ically ill children taking the magnitude of inflammatory
response and nutritional status, among other variables,
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Figure 1 Effect of malnutrition on low plasma selenium concentrations (odds ratio) according to CRP values during the study period.
The solid line represents the odds ratio; dotted lines represent the 95% confidence interval limits. CRP, C-reactive protein.
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low plasma selenium concentration risk. As represented in
Figure 1, the effect of malnutrition on low plasma selen-
ium concentrations depended on CRP values. When CRP
values were less than or equal to 40 mg/L, malnutrition
significantly increased the chance of low plasma selenium.
With values higher than 40 mg/L, the magnitude of
the inflammatory response prevailed over malnutrition,
which ceased to be significantly associated with the
outcome. Similarly, there was a significant affect of CRP
concentrations on low plasma selenium in well-nourished
patients but not in the malnourished. Malnutrition must
be considered when understanding low plasma selenium
concentrations, especially in patients in which the in-
flammatory response is not as severe. In this context,
malnutrition somewhat reduced the importance of CRP
concentrations on low plasma selenium risk. Therefore,
one must consider both factors - the magnitude of the
inflammatory response as well as nutritional status when
interpreting plasma selenium concentrations in patients
under metabolic stress.
Study limitations
The main limitation of this study was defining the low
plasma selenium outcome variable based on the median
study sample selenium value. In our study, the definition
of the median as a cutoff was adopted because, similar
to other adult and child studies [6-10,16-18], plasma
selenium concentrations were below the lower limit in
most patients. This factor coupled with the high prevalence
of malnutrition in our ICU plus the evidence of selenium
deficiency in some areas of Brazil [14,15], should be
considered when generalizing these results to other units
with different profile. In addition, the relation betweenmalnutrition and selenium deficiency should be nuanced.
Although multiple micronutrient deficiencies are inherent
in malnutrition, selenium deficiency may occur without
visible protein-energy malnutrition depending on the
selenium content of the food. Hence, the link between
malnutrition and nutritional selenium deficiency depends
on the selenium content of the soil and food [47] and on
the type of malnutrition.
It is well established that selenium is an essential micro-
nutrient for antioxidant defenses that has reduced plasma
concentrations during a systemic inflammatory response.
However, the benefit of selenium supplementation in all
critically ill patients is still not proven. Meta-analyses have
shown that high-dose selenium might have beneficial
effects in patients with sepsis syndrome, but there are
significant heterogeneity of protocols, patients and out-
comes in the different trials [10,48-51].
The results of our study show that low plasma concen-
trations are not necessarily indicative of systemic inflam-
mation only, but may also reflect nutritional deficiency.
Low plasma selenium concentrations in malnourished
patients may be an indication for supplementation, whereas
this does not necessarily mean that all patients with low
plasma selenium should be supplemented. Importantly, an
interpretation that considers only plasma selenium concen-
trations and omits nutritional status may have implications
for nutritional therapy in patients undergoing a systemic
inflammatory response. Although there are no reports of
adverse effects of selenium supplementation for a short
period of time in critically ill patients, it is worth consider-
ing that high selenium compound concentrations are toxic
and that sodium selenite may also act as an oxidant
molecule [3,34,52,53]. Adjusted hazard ratios for serum
selenium-induced all-cause mortality among US adults
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may benefit people with low plasma selenium concentra-
tions, those with adequate to high concentrations might be
affected adversely and should not be supplemented [1,52].
Supplementation with doses around or below the tolerable
upper intake (UL for adults is 400 μg/day) should be suffi-
cient to correct previous selenium deficiency in critically ill
patients [34,54].
Conclusions
In this study, we have shown that the magnitude of the
inflammatory response and malnutrition are associated
with low plasma selenium in children admitted to the
ICU. There is a significant interaction between these two
factors on plasma selenium concentrations. This interaction
should be considered when interpreting plasma con-
centrations as an index of selenium status in patients
with systemic inflammation as well as in the decision
on selenium supplementation.
Key messages
 There is an interaction between the magnitude of
the inflammatory response and malnutrition on low
plasma selenium concentrations in critically ill
children. Interaction between variables is present when
the effect of one predictor variable on the outcome
varies according to the other independent variable.
 The effect of malnutrition on low plasma selenium
depends on CRP concentrations. At CRP values less
than or equal to 40 mg/L malnutrition increased the
chance of low plasma selenium. This effect decreased
according to the CRP concentration increase and was
no longer significant from values >40 mg/L. In turn,
the effect of CRP concentrations on low plasma
selenium depends on whether the child is
malnourished or not. This effect was significant in
well-nourished but not in malnourished patients.
 The interaction between CRP and malnutrition
should be considered when interpreting plasma
concentrations as an index of selenium status in
patients with systemic inflammation as well as in the
decision on selenium supplementation.
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